首页 | 本学科首页   官方微博 | 高级检索  
     

异环磷酰胺为主化疗方案在儿童恶性疾病中的应用
引用本文:汤静燕,王耀平,梁辉,郑伟敏. 异环磷酰胺为主化疗方案在儿童恶性疾病中的应用[J]. 白血病.淋巴瘤, 1996, 0(3)
作者姓名:汤静燕  王耀平  梁辉  郑伟敏
作者单位:上海新华医院
摘    要:1993年11月至1995年1月18例小儿恶性肿瘤病人接受异环磷酰胺为主的化疗共38个疗程,异环磷酰胺剂量为每次1.3~1.7g/M2×5天,同时每天给予每克异环环磷酰胺1.2g美斯纳及水化、碱化,结果表明异环磷酰胺在上述用法时较为安全,可以避免主要毒性反应一出血性膀胱炎,骨随抑制时间较为短暂,未发生致死性感染,无明显肝脏毒性作用。3~12个月短期随访结果显示异环磷酰胺对B细胞型恶性淋巴瘤、神经母细胞瘤、横纹肌肉危及肾母细胞瘤有明显效果,并在环磷酰胺抗药时仍有效。

关 键 词:异环磷酰胺,毒性作用,疗效

IFOSFAMIDE-BASED CHEMOTHERAPY IN CHILDREN WITH MALIGNANI TUMOR
Tang JingYan,Wang Yaopin,Liang hui,et al. IFOSFAMIDE-BASED CHEMOTHERAPY IN CHILDREN WITH MALIGNANI TUMOR[J]. Journal of Leukemia & Lymphoma, 1996, 0(3)
Authors:Tang JingYan  Wang Yaopin  Liang hui  et al
Abstract:cmdren with malignant tumor received ifosfamide-based intensive chemother-apy for 38 protocals from 1993.1 to 1995.1.The dose of ifosfamide was 1.g/m2/d,otal 5days,companied with mesf1a 1.g/every 1g ifosfamide/d,hydration and basification. The re-sult showed that the dosage limited bladder hemorrhage could be avoided,and bone marrow sup-pression was short.Life threatening infections and obvious Iiver toxici ty were not found.3-12months following-p indicated that ifosfamide is an effective drug to B type non-Hodgkin'slymphoma,neuroblastoma,wilm's tumor and rhabdomyoblastoma even in some CTX resistancecases.
Keywords:Ifosfamide Toxic effect Curative effect  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号